| You are receiving this as part of your subscription to Cannabis Profits Daily. To remove your email from this list, unsubscribe here. | | | | February 28, 2020
| Cannabis Is Taking on the $1.2 Trillion Pharmaceutical Market Michael Robinson | Editor's Note: Advisory Board member Michael A. Robinson is a 35-year Silicon Valley veteran and one of the top technology financial analysts working today. And he has a special report this month that he wanted to make sure all members of the National Institute for Cannabis Investors could access... |
The legalization of cannabis will probably go down in history as one of the greatest advancements in medical history. I'm talking about a discovery as powerful as penicillin or learning how germs cause diseases.
With cannabis, the world of medicine has a real wonder drug on its hands.
I've said it before, but it's worth saying again. Cannabis is the world's only universal drug because the human body is specifically wired to accept it.
To put this in more precise terms, cannabis has been identified as a potential treatment for no less than 172 different medical conditions.
There may well be more.
Already, though, we know that the conditions that can be treated with the help of cannabis include severe and notorious diseases like cancer, multiple sclerosis, glaucoma, epilepsy, and chronic pain.
Looking at these sectors of the pharmaceutical industry in terms of market size shows us that medical cannabis has plenty of room to expand.
And as it expands, it's building a new wave of wealth for investors... | | | | | | | | "As Far as I'm Concerned - This Is the Industry's Most Important Trend" | | When we asked legendary quarterback Joe Montana to share his number one trend in the cannabis industry, his answer surprised us. But a chance encounter with his mother-in-law helped us understand a little bit better. And the more we looked into it... the more it all started to come together. Because the fact is, this niche of the industry is projected to hit $148 billion in just a couple short years. Right now, ordinary people have a chance to invest in this subsector before the big guns get in. Joe Montana and three of the other brightest minds in cannabis are showing you how right here. | | | The countdown clock to federal legalization is running out... And when time is up, we're expecting it to blow the doors off Wall Street with a nearly unprecedented infusion of cash. Because the fact is, the market potential here is unlike anything we've seen before. Experts are expecting a 3,400% increase in medical cannabis alone. And edibles? They could be worth nearly $8.4 BILLION by 2022. But you can't go into this market blind. That's where the 2020 Pot Profits Roadmap comes in - and we have 500 copies to give out today. Find out how you could capitalize on what we believe is going to be a tidal wave of cannabis cash by learning how to claim your copy today... before it's too late. | | | | | | You are receiving this e-mail at its028@gmail.com, as a part of your subscription to Cannabis Profits Daily.
Remove your email from this list: Unsubscribe
© 2020 The National Institute for Cannabis Investors All Rights Reserved The National Institute for Cannabis Investors | 1125 N Charles Street | Baltimore, MD 21201 Toll Free: 866.260.0361; International: 410.777.8270 Contact Customer Service Website: https://nicinvestors.com
Nothing in this email should be considered personalized financial advice. Although our employees may answer your general customer service questions, they are not licensed under securities laws to address your particular investment situation. No communication by our employees to you should be deemed as personalized financial advice.
We expressly forbid our writers from having a financial interest in any security recommended to our readers. All of our employees and agents must wait 24 hours after on-line publication or 72 hours after the mailing of printed-only publication prior to following an initial recommendation. Any investments recommended in this letter should be made only after consulting with your financial adviser and only after reviewing the prospectus or financial statements of the company.
Protected by copyright laws of the United States and international treaties. This information may only be used pursuant to the subscription agreement and any reproduction, copying, or redistribution (electronic or otherwise, including on the world wide web), in whole or in part, is strictly prohibited without the express written permission of The National Institute for Cannabis Investors, 1125 N Charles Street, Baltimore, MD 21201.
Privacy Policy | Terms & Conditions | |
没有评论:
发表评论